Ignite Creation Date:
2025-12-25 @ 12:37 AM
Ignite Modification Date:
2026-01-29 @ 4:51 PM
Study NCT ID:
NCT02868567
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-11
First Post:
2016-03-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Use of Dalfampridine in Primary Lateral Sclerosis
Sponsor:
Hospital for Special Surgery, New York
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
2016-247
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None